A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors
Trial · NCT00557856
Results by group1,210
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 1,210
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Maximum Tolerated Dose (MTD): Part 1 | PF-03446962 | 10.0 | milligram/kilogram (mg/kg) | ||
| Recommended Phase 2 Dose (RP2D): Part 1 | PF-03446962 | 7.0 | mg/kg | ||
| Number of Participants With Treatment-Emergent Adverse Events (AEs): Part 1 and Part 2 | PF-03446962 0.5 mg/kg: Part 1 | All causalities | 5 | participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs): Part 1 and Part 2 | PF-03446962 1 mg/kg | All causalities | 5 | participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs): Part 1 and Part 2 | PF-03446962 2 mg/kg : Part 1 | All causalities | 6 | participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs): Part 1 and Part 2 | PF-03446962 3 mg/kg: Part 1 | All causalities | 3 | participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs): Part 1 and Part 2 | PF-03446962 4.5 mg/kg: Part 1 | All causalities | 4 | participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs): Part 1 and Part 2 | PF-03446962 6.75 mg/kg: Part 1 | All causalities | 8 | participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs): Part 1 and Part 2 | PF-03446962 10 mg/kg: Part 1 | All causalities | 7 | participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs): Part 1 and Part 2 | PF-03446962 15 mg/kg: Part 1 | All causalities | 6 | participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs): Part 1 and Part 2 | PF-03446962 7 mg/kg: Part 2 | All causalities | 24 | participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs): Part 1 and Part 2 | PF-03446962 0.5 mg/kg: Part 1 | Treatment-related | 4 | participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs): Part 1 and Part 2 | PF-03446962 1 mg/kg | Treatment-related | 2 | participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs): Part 1 and Part 2 | PF-03446962 2 mg/kg : Part 1 | Treatment-related | 4 | participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs): Part 1 and Part 2 | PF-03446962 3 mg/kg: Part 1 | Treatment-related | 1 | participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs): Part 1 and Part 2 | PF-03446962 4.5 mg/kg: Part 1 | Treatment-related | 3 | participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs): Part 1 and Part 2 | PF-03446962 6.75 mg/kg: Part 1 | Treatment-related | 7 | participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs): Part 1 and Part 2 | PF-03446962 10 mg/kg: Part 1 | Treatment-related | 6 | participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs): Part 1 and Part 2 | PF-03446962 15 mg/kg: Part 1 | Treatment-related | 2 | participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs): Part 1 and Part 2 | PF-03446962 7 mg/kg: Part 2 | Treatment-related | 20 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00557856/results